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Extranodal natural killer/T cell lymphoma, nasal type, is a non-Hodgkin lymphoma, most commonly affecting the
nasal cavity, paranasal sinuses and nasopharynx. Clinically it is characterised by destruction of facial tissues,
commencing in the midline. In most cases it arises from malignant transformation of natural killer cells (NK);
sometimes from malignant transformation of cytotoxic T cells.
Extranodal NK/T cell lymphoma, nasal type, is rare, but even more rare in black persons. The purpose of this article
is to report a severe case of extranodal NK/T cell lymphoma, nasal type, in an elderly black male.
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Extranodal natural killer/T cell (NK/T cell) lymphoma,
nasal type, is a rare non-Hodgkin lymphoma originating
in the nasal cavity or in the paranasal sinuses. It is
strongly associated with Epstein-Barr virus (EBV) infec-
tion. Its prevalence is higher in countries in South-East
Asia and in Central and South America than in Europe
and in North America; it occurs in middle-aged persons
and affects males more frequently than females [1-5].
Most cases arise from natural killer cells, only a few
from cytotoxic T-cells [6,7].
Clinically, extranodal NK/T cell lymphoma, nasal type,
is characterized by progressive midline facial destruction.
Initial signs and symptoms include nasal stuffiness, epi-
staxis and pain, owing to progressive tumour growth in
the nose. As the tumour mass enlarges, invading and
destroying structures in the upper anterior aerodigestive
tract, it becomes progressively necrotic with a purulent
discharge. Signs and symptoms are related to the sites
involved. Secondary infection and haemorrhage are not
infrequent [5,6]. Metastasis is uncommon [8].
As extranodal NK/T cell lymphoma, nasal type, may clin-
ically mimic other destructive disease entities affecting
mid-facial structures including other lymphomas, nasopha-
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reproduction in any medium, provided the orgranulomatosis and fungal infections, the definitive diagno-
sis must be based on histopathological, immunological and
molecular studies [5].
Localised extranodal NK/T cell lymphoma, nasal type
usually responds favourably to radiotherapy. As in any
neoplasm the best clinical outcome is achieved when
treatment is started early in the course of the disease;
but once the tumour has invaded, radiotherapy must be
supplemented with chemotherapy. Nevertheless, local
recurrence occurs in about 50% of cases. Extensive local
invasion, regional lymph node involvement, elevated
serum lactate dehydrogenase, raised EBV DNA titres
and systemic signs (fever, night sweats, weight loss) are
associated with a poor prognosis [3,4,6,9-11], and over-
all, the prognosis is poor. The five year survival rate is
reportedly between 38% and 85%.
About 25% of lymphomas that fulfil the histological, im-
munological and molecular criteria of diagnosis for extra-
nodal NK/T cell lymphoma, nasal type, may arise in other
sites of the upper aerodigestive tract (e.g. nasopharynx,
palate), and in sites outside the upper aerodigestive tract
including the skin, the gastrointestinal tract and the testis
[12]. It appears that no matter where it arises in the upper
aerodigestive tract, the course of the disease is similar; but
when it arises at other sites it runs a more aggressive clin-
ical course [12,13], frequently disseminating to the spleen,
skin or to bone marrow [1,11,14].
To our knowledge, the prevalence of extranodal NK/T
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known [12]. We report a case of extranodal NK/T cell
lymphoma, nasal type, in an elderly black male, that caused
extreme destruction and deformity of the midface.
Case report
A 74-year old black male was referred to the Dr George
Mukhari Hospital in Ga Rankuwa, Pretoria with midline
facial destruction (Figure 1).
The patient stated that about a year before, a small
growth had appeared on his nose, became ulcerated and
then enlarged progressively. As the lesion enlarged, his
nose became blocked with a discharge, he frequently
had headaches, and the sight of his left eye deteriorated.
However, owing to his destitute circumstances, it was
about a year before he was brought to hospital. He does
not smoke or drink alcohol, and had been in good health
until the facial condition started.
On admission to hospital he had a fever, headache, con-
junctivitis, swelling of the eyelids and of the lower part of
the nose, and destruction of the entire midface with indu-
rated swelling of the surrounding tissues (Figure 1). There
were no intraoral or extra-facial cutaneous lesions, the re-
gional lymph nodes were not enlarged, and clinically and
radiologically the chest was normal.
Intravenous fluids and antibiotics were given and daily
irrigation of the wound was started. The patient was not
anaemic, was HIV-seronegative and did not have syph-
ilis. There was leucocytosis but not lymphocytosis, andFigure 1 Destruction of the midface with swelling of
surrounding facial tissues and lower part of the nose.the erythrocyte sedimentation rate, C-reactive protein
and lactate dehydrogenase were elevated. Serum IgG
was present, but not IgM to EBV cuspid antigen.
Computed tomographic (CT) scans showed radiopa-
city of a degree consistent with a soft tissue encroach-
ment in the nasal cavity, both maxillary sinuses, ethmoidal,
frontal and sphenoidal sinuses, and the nasopharynx
(Figures 2 and 3).
Biopsy of the tissue from the nasal mass showed a
dense polymorphic cell infiltrate consisting of histio-
cytes, eosinophils and a great number of atypical lymph-
oid cells in an angiocentric distribution. The atypical
lymphoid cells exhibited large nuclei, hyperchromatism,
and some of them exhibited abnormal mitotic figures
(Figure 4A). Areas of necrosis were evident.
Immunophenotypically, the tumour cells were posi-
tive for CD3 and CD56 (Figure 4B), but negative for
CD20. Some of the large atypical lymphocytes were
positive for CD30.
No facilities were available for in situ hybridization
analysis which might have demonstrated whether the
malignant cells harboured EBV small-encoded RNA.
As the clinical and histological features were consist-
ent with a diagnosis of extranodal NK/T cell lymphoma,
nasal type, the patient was referred to the oncology de-
partment for treatment, but he died soon after.
Discussion
In the past, progressive destructive necrotic lesions in-
volving the midface, the nose, paranasal sinuses and
mouth, were referred to by the generic name ‘midline
lethal granulomata’. However, with the advent of
immuno-histochemical phenotyping methods it has be-
come evident that ‘midline lethal granuloma’ comprisesFigure 2 Coronal C.T: destruction of the medial walls of the
maxillary sinuses and veiling of maxillary sinuses, ethmoidal
sinus, frontal sinus and the nasal cavity.
Figure 3 Axial C.T: homogeneous soft tissue mass filling the
anterior nasal cavity with bilateral obliteration of the maxillary
sinuses, nasal cavity and the posterior nasal space. Note the
destruction of the anterior portion of the face, including the nose.
Figure 4 NK/T cell lymphoma, nasal type. A: atypical
lymphocytes arranged in a vaguely angiocentric pattern (H&E,
original magnification X 40). B: atypical lymphocytes positive for
CD56 (original magnification X 40).
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lymphoma, Wegener granulomatosis and various granu-
lomatous infections [2].
Extranodal NK/T cell lymphoma, nasal type, accounts
for 7-10% of all non-Hodgkin lymphomas in Asia and
Latin America, but for only 1% in Europe and North
America [8,12,15]. In Korea, it accounts for about 75%
of lymphomas arising within the nasal cavity and the
paranasal sinuses [11]. To the knowledge of the authors,
the prevalence of the disease in black South Africans,
and indeed in black persons in general is unknown, but
it appears to be very low.
Extranodal NK/T cell lymphoma, nasal type, is charac-
terized histopathologically by angiocentric and angiodes-
tructive growth, by tumour cells that vary in size and
may harbour EBV in a clonal episomal form, and by an
inflammatory cell infiltrate of plasma cells, histiocytes
and eosinophils [1].
Immunophenotypically, the malignant tumour cells,
like the natural killer cells from which they originate
express CD2, cytoplasmic CD3 and CD56. In some cases
they may also express cytotoxic granular-associated
proteins, granzyme B, perforin, and T cell-restricted
intracellular antigen (TIA-1). Genotypically, the malig-
nant tumour cell expresses the T cell receptor gene in its
germline configuration, but there is no monoclonal
rearrangement of the T cell receptor [1]. However, thereare cases in which the malignant cells lack CD56 and
thus do not express the classic phenotype of NK cells; or
they express an aberrant profile of CD8+ T cell antigens.
Nevertheless these are well-recognised subsets of extrano-
dal NK/T cell lymphoma, nasal type, because the clinical
and histological features are characteristic [1].
As NK cells and T cells may arise from common pro-
genitor cells, NK cells may express some T cell antigens,
and T cells may express some NK cell antigens, so that
cells of extranodal NK/T cell lymphoma, nasal type, may
express both NK cell and T cell antigens [8].
Our patient’s tumour showed an angiocentric pattern
of growth, and immunophenotypically, the tumour cells
were CD56 positive, confirming the histological diagno-
sis of extranodal NK/T cell lymphoma, nasal type. Some
extranodal NK/T cell lymphomas, nasal type consist of
large cells expressing CD30 [1], and as the large atypical
cells in our case were positive for CD30, the contention
that our case is indeed extranodal NK/T cell lymphoma,
nasal type, is supported.
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do not possess surface CD3 which is a T cell antigen. Since
immuno-histochemical studies of paraffin sections with
polyclonal anti-CD3 antibodies will disclose both cytoplas-
mic and surface CD3, this method cannot discriminate
between NK cells and T cells. In order to distinguish be-
tween NK cells and T cells using cytoplasmic CD3 as a
marker, immuno-histochemical studies must be performed
on fresh-frozen tissue. Although, the immunohistochem-
ical studies in our case were done on paraffin sections and
not on fresh-frozen tissue, rendering the positive staining
for CD3 inconclusive, nevertheless, this together with
CD56 positivity, confirms an NK phenotype.
In the nose and paranasal sinuses, extranodal NK/T
cell lymphoma, nasal type, is characterized by extensive
local destruction of soft tissue, cartilage and bone,
brought about by the aggressive angiocentric and
angioinvasive nature of the tumour that results in func-
tional incompetence of the vasculature with consequent
ischaemia. This, together with the effect of cytotoxic
molecules, including perforin, granzyme B and TIA-1
released by the malignant NK cells, and together with
the tumour-associated inflammatory process, cause the
widespread tissue damage and necrosis [4,6,16].
Typically, as seen on CT scans, the established soft tis-
sue tumour obliterates the nasal passages and frequently
invades and obliterates the maxillary sinuses [17]. Our
patient presented with extensive facial destruction, and
his extranodal NK/T cell lymphoma, nasal type, was
diagnosed only late in the course of the disease, about
one year after the initial symptoms. By then the tumour
had already largely destroyed the structure of the nose
and had invaded the maxillary, ethmoidal, frontal and
sphenoidal sinuses, and the nasopharynx.
The extent of invasion by the tumour is classified by
stages: T1 refers to a tumour confined to the nose; T2 to
additional tumour invasion of the maxillary and anterior
ethmoidal sinuses and/or the hard palate; T3 to further
tumour invasion involving the posterior ethmoidal
sinuses, sphenoidal sinuses, orbit, maxillary alveolar
process of bone, and buccal tissues; and T4 to tumour
invasion extending to the mandibular alveolar process of
bone, to the infratemporal fossa, to the nasopharynx and
to the cranial fossa [11,17]. Our patient was at the T3/
T4 stage of the tumour.
The almost invariable presence of EBV in a latent
clonal episomal form in the cells of the extranodal NK/T
cell lymphoma, nasal type, strongly suggests a direct role
of the virus in the pathogenesis of the tumour [1,6,18].
EBV infects the NK/T cells and establishes latent infec-
tion before initial transformation of NK/T cells has
occurred, prior to the clonal divergence and clonal ex-
pansion of the cancerous cells. The presence of this clo-
notypic EBV genome in a latent form in the tumourcells strongly supports, but does not prove the patho-
genic role of EBV in NK/T lymphomagenesis [7,19].
The active involvement of EBV in the pathogenesis of
extranodal NK/T cell lymphoma, nasal type, is further
supported by the direct positive correlation between
EBV load in the tumour and the extent of the disease,
and by the high titres of IgG antibodies to EBV in per-
sons with the disease. Plasma titre of EBV DNA serves
as a marker of tumour viral burden and fluctuates with
the status of the disease and the response to treatment
because EBV DNA fragments are released from apop-
totic tumour cells and escape into the circulation [4,6,8].
At our hospital there are no facilities for in-situ
hybridization studies, so we do not know whether or not
the cells of the extranodal NK/T cell lymphoma, nasal
type, of our patient carried EBV encoded early RNA, but
serological studies showed that our patient had IgG but
not IgM, to EBV cuspid antigen, indicative of either past
EBV infection, or of current latent infection.
Conclusion
We present a case of extranodal NK/T cell lymphoma,
nasal type in an elderly black male. This tumour appears
to be rare in black persons, as we could find only a few
cases reported in the literature. It may well be that the
incidence is higher, but because cases in remote rural
communities in sub-Saharan Africa are unlikely to be
reported, the epidemiology of the tumour in this geo-
graphic area is unknown.
The purpose of this article is to add to the information
available with regard to extranodal NK/T cell lymphoma,
nasal type in black persons in the hope that data gath-
ered from single case reports will help to characterise
this disease in black persons, and to help identify the
biological/environmental factors which confer protection
against developing the disease in this population group.
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